Polymorphisms in PPARG, particularly the proline-to-alanine substitution at aminoacid position 12, have been associated with diabetes, insulin levels, insulin sensitivity, body mass index, and dyslipidemia [37–40] (Table 1). This evidence concerns the gene PPARG and diabetes mellitus.